{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_vemurafenib",
          "name": "Vemurafenib"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_dabrafenib",
          "name": "Dabrafenib"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_trametinib",
          "name": "Trametinib"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_sunitinib",
          "name": "Sunitinib"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_sorafenib",
          "name": "Sorafenib"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_everolimus",
          "name": "Everolimus"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_irinotecan",
          "name": "Irinotecan"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_carboplatin",
          "name": "Carboplatin"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_bevacizumab",
          "name": "Bevacizumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_vemurafenib",
          "type": "Drug",
          "label": "Vemurafenib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_dabrafenib",
          "type": "Drug",
          "label": "Dabrafenib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_trametinib",
          "type": "Drug",
          "label": "Trametinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_sunitinib",
          "type": "Drug",
          "label": "Sunitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_sorafenib",
          "type": "Drug",
          "label": "Sorafenib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_everolimus",
          "type": "Drug",
          "label": "Everolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_irinotecan",
          "type": "Drug",
          "label": "Irinotecan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_etoposide",
          "type": "Drug",
          "label": "Etoposide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_carboplatin",
          "type": "Drug",
          "label": "Carboplatin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_temozolomide",
          "type": "Drug",
          "label": "Temozolomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_bevacizumab",
          "type": "Drug",
          "label": "Bevacizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_familial_tumour_syndromes",
          "type": "Disease",
          "label": "Familial tumour syndromes of the central and peripheral nervous system",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_vemurafenib",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Kaplan-Meier 分析显示潜在的风险"
        },
        {
          "source": "n_dabrafenib",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "与 Vemurafenib 有相似临床特征"
        },
        {
          "source": "n_trametinib",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "临床资料表明相关风险"
        },
        {
          "source": "n_sunitinib",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "已知可能对神经系统有影响"
        },
        {
          "source": "n_sorafenib",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "其副作用可能相关"
        },
        {
          "source": "n_everolimus",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能影响病理进程"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "有可能引发合并症"
        },
        {
          "source": "n_irinotecan",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "对细胞增殖的影响值得关注"
        },
        {
          "source": "n_etoposide",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "其风险已在文献中报道"
        },
        {
          "source": "n_carboplatin",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "可能与神经病理有关"
        },
        {
          "source": "n_temozolomide",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "潜在的负面影响"
        },
        {
          "source": "n_bevacizumab",
          "target": "n_familial_tumour_syndromes",
          "relation": "causes",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "相关的查询表明风险"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多个药物显示对中枢和周围神经系统肿瘤综合征有潜在风险",
        "confidence": "medium"
      },
      {
        "id": "C2",
        "text": "成药物类群的风险提示需要关注",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物在相关应用中出现副作用的推测是基于临床数据并需后续验证"
    ],
    "uncertainties": [
      "尚需进一步研究确定确切的风险关系"
    ],
    "next_focus_for_pi": [
      "需重点关注药物与神经系统肿瘤综合征的具体机制"
    ]
  }
}